Announcements Trials
Browse Landscape

Phase

Phase 2 78Phase 1 28Phase 3 22Phase 1/2 7Phase 4 4Phase 2/3 2Phase EARLY_PHASE1 1

Status

Completed 4Terminated 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Endocrine 1

Conditions

Breast Neoplasms 3Patient Acceptance of Health Care 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Completed × Fulvestrant × Clear all
NCT05631795 2026-04-07

ALPINIST

Novartis

Phase 4 Completed
40 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed
130 enrolled
Breast

Breast Neoplasms, Patient Acceptance of Health Care

NCT04707196 2023-11-24

A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

Eli Lilly and Company

Phase 4 Completed
200 enrolled 10 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02447328 2021-09-05

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

AstraZeneca

Phase 4 Completed
83 enrolled 6 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡